Concepedia

Publication | Open Access

A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice

62

Citations

37

References

2011

Year

Abstract

DHMEQ ameliorated experimental colitis in mice. These results indicate that DHMEQ appears to be an attractive therapeutic agent for IBD.

References

YearCitations

Page 1